Negative Regulation of 26S Proteasome Stability via Calpain-mediated Cleavage of Rpn10 Subunit upon Mitochondrial Dysfunction in Neurons*

Background: Proteasomal and mitochondrial dysfunction are implicated in neurodegeneration. Results: Upon mitochondrial dysfunction in neurons, calpain-mediated cleavage of Rpn10 negatively regulates 26S proteasome stability. Conclusion: ATP deficiency and calpain-activation impair the ubiquitin/proteasome pathway with a concomitant increase in 20S proteasomes. Significance: This proteolytic switch could promote degradation of randomly unfolded oxidized proteins in an unregulated and energy-independent manner by 20S proteasomes. Proteasomal and mitochondrial dysfunctions are implicated in chronic neurodegenerative diseases. To investigate the impact of mitochondrial impairment on the proteasome, we treated rat cerebral cortical neurons with oligomycin, antimycin, or rotenone, which inhibit different elements of the electron transport chain. Firstly, we observed a reduction in ubiquitinated proteins and E1 activity. Secondly, we established that 26S proteasomes are disassembled with a decline in activity. Thirdly, we show, to our knowledge for the first time, that calpain activation triggers the selective processing of the 26S proteasome subunit Rpn10. Other proteasome subunits tested were not affected. Calpain also cleaved caspase 3 to an inactive fragment, thus preventing apoptosis that is an energy-dependent cell death pathway. In addition, calpain cleaved the microtubule-associated protein Tau, a major component of neurofibrillary tangles in Alzheimer disease and other tauopathies. Fourthly, we detected a rise in 20S proteasome levels and activity. Finally, we show that both acute (16 h) and long term (up to 7 days) mitochondrial impairment led to down-regulation of ubiquitinated-proteins, 26S proteasome disassembly, and a rise in 20S proteasomes. We postulate that upon mitochondrial dysfunction, ATP depletion and calpain activation contribute to the demise of protein turnover by the ubiquitin/proteasome pathway. The concomitant rise in 20S proteasomes, which seem to degrade proteins in an unregulated and energy-independent manner, in the short term may carry out the turnover of randomly unfolded oxidized proteins. However, if chronic, it could lead to neurodegeneration as regulated protein degradation by the ubiquitin/proteasome pathway is essential for neuronal survival.

[1]  George Perry,et al.  Abnormal mitochondrial dynamics in the pathogenesis of Alzheimer's disease. , 2012, Journal of Alzheimer's disease : JAD.

[2]  H. Sorimachi,et al.  Regulation and physiological roles of the calpain system in muscular disorders , 2012, Cardiovascular research.

[3]  Jennifer R. Shell,et al.  Proteolytic regulation of the mitochondrial cAMP-dependent protein kinase. , 2012, Biochemistry.

[4]  M. Mattson,et al.  Recruiting adaptive cellular stress responses for successful brain ageing , 2012, Nature Reviews Neuroscience.

[5]  F. Förster,et al.  Localization of the proteasomal ubiquitin receptors Rpn10 and Rpn13 by electron cryomicroscopy , 2012, Proceedings of the National Academy of Sciences.

[6]  F. Shang,et al.  Ubiquitin-proteasome pathway and cellular responses to oxidative stress. , 2011, Free radical biology & medicine.

[7]  T. Grune,et al.  Proteins bearing oxidation-induced carbonyl groups are not preferentially ubiquitinated. , 2011, Biochimie.

[8]  Hiroshi Mamitsuka,et al.  Calpain Cleavage Prediction Using Multiple Kernel Learning , 2011, PloS one.

[9]  Zexian Liu,et al.  GPS-CCD: A Novel Computational Program for the Prediction of Calpain Cleavage Sites , 2011, PloS one.

[10]  M. Glickman,et al.  Ubiquitin-proteasome system and mitochondria - reciprocity. , 2011, Biochimica et biophysica acta.

[11]  Lan Huang,et al.  Oxidative Stress-Mediated Regulation of Proteasome Complexes* , 2011, Molecular & Cellular Proteomics.

[12]  E. Mandelkow,et al.  Cleavage of Tau by calpain in Alzheimer's disease: the quest for the toxic 17 kD fragment , 2011, Neurobiology of Aging.

[13]  K. Davies,et al.  Protein oxidative modifications in the ageing brain: Consequence for the onset of neurodegenerative disease , 2011, Free radical research.

[14]  Sara G. Becker-Catania,et al.  Oligodendrocyte progenitor cells proliferate and survive in an immature state following treatment with an axolemma-enriched fraction , 2010, ASN neuro.

[15]  R. Hayes,et al.  Dual vulnerability of tau to calpains and caspase-3 proteolysis under neurotoxic and neurodegenerative conditions , 2010, ASN neuro.

[16]  N. Myeku,et al.  Assessment of proteasome impairment and accumulation/aggregation of ubiquitinated proteins in neuronal cultures. , 2011, Methods in molecular biology.

[17]  E. Bigio,et al.  Calpain-Mediated Tau Cleavage: A Mechanism Leading to Neurodegeneration Shared by Multiple Tauopathies , 2011, Molecular medicine.

[18]  J. Keller,et al.  Selective vulnerability of neurons to acute toxicity after proteasome inhibitor treatment: implications for oxidative stress and insolubility of newly synthesized proteins. , 2010, Free radical biology & medicine.

[19]  Li Chen,et al.  Synthetic lethality of rpn11-1rpn10Δ is linked to altered proteasome assembly and activity , 2010, Current Genetics.

[20]  R. Dobrowsky,et al.  Diminished Superoxide Generation Is Associated With Respiratory Chain Dysfunction and Changes in the Mitochondrial Proteome of Sensory Neurons From Diabetic Rats , 2010, Diabetes.

[21]  K. Davies,et al.  THE IMMUNOPROTEASOME, THE 20S PROTEASOME, AND THE PA28αβ PROTEASOME REGULATOR ARE OXIDATIVE STRESS‐ADAPTIVE PROTEOLYTIC COMPLEXES , 2010, The Biochemical journal.

[22]  D. Schubert,et al.  The specificity of neuroprotection by antioxidants , 2009, Journal of Biomedical Science.

[23]  H. Wong,et al.  Age‐related decrease in proteasome expression contributes to defective nuclear factor‐κB activation during hepatic ischemia/reperfusion , 2009, Hepatology.

[24]  J. Lowe,et al.  The UPS and autophagy in chronic neurodegenerative disease: Six of one and half a dozen of the other—Or not? , 2009, Autophagy.

[25]  D. Nicholls.  Oxidative Stress and Energy Crises in Neuronal Dysfunction , 2008, Annals of the New York Academy of Sciences.

[26]  Alberto Pupi,et al.  Brain Glucose Hypometabolism and Oxidative Stress in Preclinical Alzheimer's Disease , 2008, Annals of the New York Academy of Sciences.

[27]  M. Brand,et al.  High membrane potential promotes alkenal-induced mitochondrial uncoupling and influences adenine nucleotide translocase conformation , 2008, The Biochemical journal.

[28]  L. Papa,et al.  Persistent mitochondrial dysfunction and oxidative stress hinder neuronal cell recovery from reversible proteasome inhibition , 2008, Apoptosis.

[29]  S. Oddo,et al.  The ubiquitin-proteasome system in Alzheimer's disease , 2008, Journal of cellular and molecular medicine.

[30]  K. Uchida,et al.  15-Deoxy-Δ12,14-prostaglandin J2: An Electrophilic Trigger of Cellular Responses , 2008 .

[31]  P. Reddy,et al.  Mitochondrial dysfunction in aging and Alzheimer's disease: strategies to protect neurons. , 2007, Antioxidants & redox signaling.

[32]  A. Goldberg.  Functions of the proteasome: from protein degradation and immune surveillance to cancer therapy. , 2007, Biochemical Society transactions.

[33]  Yoonkey Nam,et al.  Development of astroglial cells in patterned neuronal cultures , 2007, Journal of biomaterials science. Polymer edition.

[34]  M. Beal,et al.  Mitochondrial dysfunction and oxidative stress in neurodegenerative diseases , 2006, Nature.

[35]  Hongtao Yu,et al.  ATP binding and ATP hydrolysis play distinct roles in the function of 26S proteasome. , 2006, Molecular cell.

[36]  Jeffrey N Keller,et al.  Proteasome regulation of oxidative stress in aging and age-related diseases of the CNS. , 2006, Antioxidants & redox signaling.

[37]  W. Zong,et al.  Necrotic death as a cell fate. , 2006, Genes & development.

[38]  M. Beal,et al.  Mitochondria take center stage in aging and neurodegeneration , 2005, Annals of neurology.

[39]  E. Berry,et al.  Binding of the respiratory chain inhibitor antimycin to the mitochondrial bc1 complex: a new crystal structure reveals an altered intramolecular hydrogen-bonding pattern. , 2005, Journal of molecular biology.

[40]  Robert W Berry,et al.  Tau, tangles, and Alzheimer's disease. , 2005, Biochimica et biophysica acta.

[41]  K. Davies,et al.  Decreased proteolysis caused by protein aggregates, inclusion bodies, plaques, lipofuscin, ceroid, and 'aggresomes' during oxidative stress, aging, and disease. , 2004, The international journal of biochemistry & cell biology.

[42]  R. Deshaies,et al.  Multiubiquitin Chain Receptors Define a Layer of Substrate Selectivity in the Ubiquitin-Proteasome System , 2004, Cell.

[43]  Jeffrey N Keller,et al.  Proteasome Inhibition Alters Neural Mitochondrial Homeostasis and Mitochondria Turnover* , 2004, Journal of Biological Chemistry.

[44]  Michael Butterworth,et al.  Caspase activation inhibits proteasome function during apoptosis. , 2004, Molecular cell.

[45]  M. Vitale,et al.  Differential kinetics of propidium iodide uptake in apoptotic and necrotic thymocytes , 1993, Histochemistry.

[46]  Keiji Tanaka,et al.  An endogenous electrophile that modulates the regulatory mechanism of protein turnover: inhibitory effects of 15-deoxy-Delta 12,14-prostaglandin J2 on proteasome. , 2003, Biochemistry.

[47]  J. Turrens,et al.  Mitochondrial formation of reactive oxygen species , 2003, The Journal of physiology.

[48]  Sten Orrenius,et al.  Calcium: Regulation of cell death: the calcium–apoptosis link , 2003, Nature Reviews Molecular Cell Biology.

[49]  K. Davies,et al.  Ubiquitin Conjugation Is Not Required for the Degradation of Oxidized Proteins by Proteasome* , 2003, The Journal of Biological Chemistry.

[50]  N. Shibata,et al.  15-Deoxy-Δ12,14-prostaglandin J2: The endogenous electrophile that induces neuronal apoptosis , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[51]  M. Bolotin-Fukuhara,et al.  Mitochondrial effects of the pleiotropic proteasomal mutation mpr1/rpn11: uncoupling from cell cycle defects in extragenic revertants. , 2002, Gene.

[52]  J. Andersen,et al.  Glutathione decreases in dopaminergic PC12 cells interfere
with the ubiquitin protein degradation pathway: relevance 
for Parkinson's disease? , 2002, Journal of neurochemistry.

[53]  D. Nicholls,et al.  The mechanism of mitochondrial membrane potential retention following release of cytochrome c in apoptotic GT1-7 neural cells , 2001, Cell Death and Differentiation.

[54]  F. Shang,et al.  Removal of oxidatively damaged proteins from lens cells by the ubiquitin-proteasome pathway. , 2001, Experimental eye research.

[55]  Kevin K. W Wang,et al.  Calpain and caspase: can you tell the difference? , 2000, Trends in Neurosciences.

[56]  T. Reinheckel,et al.  Comparative resistance of the 20S and 26S proteasome to oxidative stress. , 1998, The Biochemical journal.

[57]  W. Baumeister,et al.  A Subcomplex of the Proteasome Regulatory Particle Required for Ubiquitin-Conjugate Degradation and Related to the COP9-Signalosome and eIF3 , 1998, Cell.

[58]  M. Degli Esposti.  Inhibitors of NADH-ubiquinone reductase: an overview. , 1998, Biochimica et biophysica acta.

[59]  J. Blumberg,et al.  Regulation of Ubiquitin-conjugating Enzymes by Glutathione Following Oxidative Stress* , 1997, The Journal of Biological Chemistry.

[60]  D. Peterson,et al.  Mechanism of Cellular 3‐(4,5‐Dimethylthiazol‐2‐yl)‐2,5‐Diphenyltetrazolium Bromide (MTT) Reduction , 1997, Journal of neurochemistry.

[61]  E. Stadtman,et al.  Reactive oxygen-mediated protein oxidation in aging and disease. , 1997, Chemical research in toxicology.

[62]  M H Zwietering,et al.  Characterization of uptake and hydrolysis of fluorescein diacetate and carboxyfluorescein diacetate by intracellular esterases in Saccharomyces cerevisiae, which result in accumulation of fluorescent product , 1995, Applied and environmental microbiology.

[63]  G. Brewer,et al.  Optimized survival of hippocampal neurons in B27‐supplemented neurobasal™, a new serum‐free medium combination , 1993, Journal of neuroscience research.

[64]  M. Berridge,et al.  Characterization of the cellular reduction of 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT): subcellular localization, substrate dependence, and involvement of mitochondrial electron transport in MTT reduction. , 1993, Archives of biochemistry and biophysics.

[65]  S. Hoyer.  Oxidative energy metabolism in Alzheimer brain. Studies in early-onset and late-onset cases. , 1992, Molecular and chemical neuropathology.

[66]  A. Hershko,et al.  ATP-dependent incorporation of 20S protease into the 26S complex that degrades proteins conjugated to ubiquitin. , 1989, Proceedings of the National Academy of Sciences of the United States of America.

[67]  K. Davies,et al.  Macroxyproteinase (M.O.P.): a 670 kDa proteinase complex that degrades oxidatively denatured proteins in red blood cells. , 1989, Free radical biology & medicine.

[68]  T. Mosmann.  Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. , 1983, Journal of immunological methods.

[69]  M. Orłowski,et al.  Evidence that Pituitary Cation‐Sensitive Neutral Endopeptidase Is a Multicatalytic Protease Complex , 1983, Journal of neurochemistry.